61718-82-9 | (2Z)-but-2-enedioic acid; (E)-(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine

Packsize	Purity	Availability	Price	Discounted Price
10mg	95%	in stock	$42.00	$29.00
1g	95%	in stock	$42.00	$30.00
5g	95%	in stock	$106.00	$75.00
25g	95%	in stock	$323.00	$226.00
100g	95%	in stock	$876.00	$614.00

Description

• Catalog Number: AI53751
• Chemical Name: (2Z)-but-2-enedioic acid; (E)-(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine
• CAS Number: 61718-82-9
• Molecular Formula: C19H25F3N2O6
• Molecular Weight: 434.4068
• MDL Number: MFCD00269809
• SMILES: OC(=O)C=CC(=O)O.NCCO/N=C(/c1ccc(cc1)C(F)(F)F)CCCCOC

Computed Properties

• Complexity: 446
• Covalently-Bonded Unit Count: 2
• Defined Bond Stereocenter Count: 2
• Heavy Atom Count: 30
• Hydrogen Bond Acceptor Count: 11
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 11

Literature

• Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.

  Chemical research in toxicology 20170515

• Fluvoxamine inhibits some inflammatory genes expression in LPS/stimulated human endothelial cells, U937 macrophages, and carrageenan-induced paw edema in rat.

  Iranian journal of basic medical sciences 20160901

• Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.

  Toxicology letters 20160122

• Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.

  Toxicology in vitro : an international journal published in association with BIBRA 20151001

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Fluvoxamine by itself has potential to directly induce long QT syndrome at supra-therapeutic concentrations.

  The Journal of toxicological sciences 20150201

• A case of akathisia induced by escitalopram: case report & review of literature.

  Current drug safety 20140301

• Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).

  Toxicological sciences : an official journal of the Society of Toxicology 20131201

• Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.

  Toxicological sciences : an official journal of the Society of Toxicology 20131201

• Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.

  Journal of applied toxicology : JAT 20130201

• GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder.

  Journal of affective disorders 20121215

• Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine.

  European journal of pharmacology 20121205

• Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test.

  Behavioural brain research 20121201

• In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine.

  Molecular pharmacology 20121101

• Acute treatment with fluvoxamine elevates rat brain serotonin synthesis in some terminal regions: an autoradiographic study.

  Nuclear medicine and biology 20121001

• Palmitate increases the susceptibility of cells to drug-induced toxicity: an in vitro method to identify drugs with potential contraindications in patients with metabolic disease.

  Toxicological sciences : an official journal of the Society of Toxicology 20121001

• Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.

  CNS drugs 20121001

• A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: a preliminary study.

  Journal of clinical psychopharmacology 20121001

• Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: a case report.

  Journal of clinical psychopharmacology 20121001

• Sigma-1 receptor agonist fluvoxamine for delirium in older adults.

  International journal of geriatric psychiatry 20120901

• Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.

  Progress in neuro-psychopharmacology & biological psychiatry 20120807

• Behavioural and pharmacological effects of fluvoxamine on decision-making in food patches and the inter-temporal choices of domestic chicks.

  Behavioural brain research 20120801

• Treatment practices in Tourette syndrome: the European perspective.

  European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20120701

• Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress.

  Free radical research 20120701

• Plasma fluvoxamine levels and OCD symptoms/response in adult patients.

  Human psychopharmacology 20120701

• Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?

  International clinical psychopharmacology 20120501

• Stereoselective metabolism of tetrahydropalmatine enantiomers in rat liver microsomes.

  Chirality 20120501

• Involvement of P-glycoprotein and cytochrome P450 3A in the metabolism of florfenicol of rabbits.

  Journal of veterinary pharmacology and therapeutics 20120401

• The potency of fluvoxamine to reduce ethanol self-administration decreases with concurrent availability of food.

  Behavioural pharmacology 20120401

• Comparison of the effects of estradiol and progesterone on serotonergic function.

  Biological psychiatry 20120401

• Fluvoxamine increased glutamate release by activating both 5-HT(3) and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice.

  Biochimica et biophysica acta 20120401

• Predicting drug candidate victims of drug-drug interactions, using microdosing.

  Clinical pharmacokinetics 20120401

• Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.

  Journal of clinical psychopharmacology 20120401

• [JSNP Excellent Presentation Award for AsCNP 2011: involvement of 5-HT(1A) receptors in fluvoxamine-induced enhancement of prefrontal dopamine release].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20120401

• Comparison of effects of a selective 5-HT reuptake inhibitor versus a 5-HT4 receptor agonist on in vivo neurogenesis at the rectal anastomosis in rats.

  American journal of physiology. Gastrointestinal and liver physiology 20120315

• Mechanisms of action of selective serotonin reuptake inhibitors in Daphnia magna.

  Environmental science & technology 20120306

• Clinical impact of fluvoxamine-mediated long QTU syndrome.

  European journal of clinical pharmacology 20120101

• The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine.

  European journal of clinical pharmacology 20120101

• Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression.

  Cardiovascular research 20120101

• Effect of fluvoxamine on the pharmokinetics of zolpidem: a two-treatment period study in healthy volunteers.

  Clinical and experimental pharmacology & physiology 20120101

• Sudden gains in the treatment of obsessive-compulsive disorder.

  Psychotherapy and psychosomatics 20120101

• [Cardioprotective effect of fluvoxamine, sigma-1 receptor high affinity agonist].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101

• Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.

  Current medicinal chemistry 20120101

• N-acetyl-L-cysteine inhibits marble-burying behavior in mice.

  Journal of pharmacological sciences 20120101

• A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.

  Internal medicine (Tokyo, Japan) 20120101

• Cognitive therapy versus fluvoxamine as a second-step treatment in obsessive-compulsive disorder nonresponsive to first-step behavior therapy.

  Psychotherapy and psychosomatics 20120101

• Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems.

  European journal of pharmacology 20111215

• 2D-3D shape reconstruction of the distal femur from stereo X-ray imaging using statistical shape models.

  Medical image analysis 20111201

• The impact of depression on the treatment of obsessive-compulsive disorder: results from a 5-year follow-up.

  Journal of affective disorders 20111201

• [First death case of serotonin syndrome in Japan induced by fluvoxamine and tandospirone].

  Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology 20111201

• [Effects of smoking and caffeine on pharmacological treatment for patients with schizophrenia and depression].

  Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20111201

• Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20111108

• Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.

  British journal of clinical pharmacology 20111101

• Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients.

  Pharmacopsychiatry 20111101

• The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.

  Journal of psychopharmacology (Oxford, England) 20111001

• Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ(1) receptor activation.

  Psychopharmacology 20111001

• Differences between early and late drop-outs from treatment for obsessive-compulsive disorder.

  Journal of anxiety disorders 20111001

• 5-HT(1A) receptor sensitivity in 5-HT(1B) receptor KO mice is unaffected by chronic fluvoxamine treatment.

  European journal of pharmacology 20110930

• Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population.

  Journal of affective disorders 20110901

• Impact of sample hemolysis on drug stability in regulated bioanalysis.

  Bioanalysis 20110901

• Clinical study on the efficacy of fluvoxamine for psychological distress in gynecologic cancer patients.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110801

• A case of pervasive developmental disorder complicated by social anxiety disorder responding well to fluvoxamine therapy.

  The Tokai journal of experimental and clinical medicine 20110720

• CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype-phenotype association study design in translational pharmacogenetics.

  Journal of psychopharmacology (Oxford, England) 20110701

• SSRI augmentation of antipsychotic alters expression of GABA(A) receptor and related genes in PMC of schizophrenia patients.

  The international journal of neuropsychopharmacology 20110601

• Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment.

  Journal of clinical psychopharmacology 20110601

• Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes.

  Toxicology letters 20110410

• A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.

  Journal of affective disorders 20110401

• The involvement of GABA(A) receptor in the molecular mechanisms of combined selective serotonin reuptake inhibitor-antipsychotic treatment.

  The international journal of neuropsychopharmacology 20110301

• Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110301

• Symptoms of agitated depression and/or akathisia.

  Psychiatria Danubina 20110301

• Beneficial effects of fluvoxamine for hemiballism in a patient with depressive disorder: a case report.

  Acta neurologica Belgica 20110301

• Automated experimental system capturing three behavioral components during murine forced swim test.

  Life sciences 20110227

• Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.

  Psychopharmacology bulletin 20110215

• Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal neurons.

  International journal of clinical and experimental pathology 20110201

• Effect of glibenclamide on antinociceptive effects of antidepressants of different classes.

  Clinics (Sao Paulo, Brazil) 20110201

• Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding.

  European journal of pharmacology 20110115

• Lithium addition to a tricyclic antidepressant results in optimal efficacy.

  Acta psychiatrica Scandinavica 20110101

• Misdiagnosis and exacerbation of unusual obsessive-compulsive disorder presentation with risperidone and clozapine in an adolescent girl - A case report.

  Collegium antropologicum 20110101

• Decrease in brain distribution of fluvoxamine in experimental hyperlipidemic rats.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20110101

• Effects of PB190 and PB212, new σ receptor ligands, on glucocorticoid receptor-mediated gene transcription in LMCAT cells.

  Pharmacological reports : PR 20110101

• [Serotoninergic mediator system in the pathogenesis and treatment of idiopathic generalized epilepsy].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101

• Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.

  BMJ case reports 20110101

• Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine.

  European psychiatry : the journal of the Association of European Psychiatrists 20101201

• Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.

  Assay and drug development technologies 20101201

• Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats.

  European journal of pharmacology 20101125

• Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice.

  American journal of physiology. Heart and circulatory physiology 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Differences in clinical effect and tolerance between fluvoxamine and paroxetine: a switching study in patients with depression.

  Human psychopharmacology 20101101

• Schizophrenia and obsessive-compulsive disorder.

  The American journal of psychiatry 20101101

• Fluvoxamine improved cognitive impairments in a patient with schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20101001

• Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions.

  Expert opinion on therapeutic targets 20101001

• HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.

  Neuromolecular medicine 20100901

• Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).

  The Cochrane database of systematic reviews 20100804

• Metabolism of ramelteon in human liver microsomes and correlation with the effect of fluvoxamine on ramelteon pharmacokinetics.

  Drug metabolism and disposition: the biological fate of chemicals 20100801

• Cabergoline, a dopamine receptor agonist, has an antidepressant-like property and enhances brain-derived neurotrophic factor signaling.

  Psychopharmacology 20100801

• Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.

  Expert review of neurotherapeutics 20100801

• Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder.

  Journal of child and adolescent psychopharmacology 20100801

• Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.

  International clinical psychopharmacology 20100701

• Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

  Postgraduate medicine 20100701

• Therapeutic efficacy assessment of weak variable magnetic fields with low value of induction in patients with drug-resistant depression.

  Journal of affective disorders 20100601

• Association analysis of SIGMAR1 with major depressive disorder and SSRI response.

  Neuropharmacology 20100601

• Selective serotonin reuptake inhibitors and the risk of cataracts: a nested case-control study.

  Ophthalmology 20100601

• Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder.

  Psychiatry and clinical neurosciences 20100601

• Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.

  Pediatrics 20100501

• Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.

  Archives of general psychiatry 20100501

• Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants.

  Journal of psychopharmacology (Oxford, England) 20100401

• Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients.

  Journal of psychopharmacology (Oxford, England) 20100401

• Interactions at human ether-à-go-go-related gene channels.

  Toxicological sciences : an official journal of the Society of Toxicology 20100401

• Protein binding-dependent decreases in hERG channel blocker potency assessed by whole-cell voltage clamp in serum.

  Journal of cardiovascular pharmacology 20100401

• Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered.

  Human psychopharmacology 20100401

• Clinical features and treatment characteristics of compulsive hoarding in Japanese patients with obsessive-compulsive disorder.

  CNS spectrums 20100401

• [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20100401

• [Customized pharmacotherapies in schizophrenia].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20100401

• [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20100401

• Involvement of the 5-HT(1A) receptor in the anti-immobility effects of fluvoxamine in the forced swimming test and mouse strain differences in 5-HT(1A) receptor binding.

  European journal of pharmacology 20100310

• Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.

  International journal of cardiology 20100304

• Predictors of treatment response to fluvoxamine in obsessive-compulsive disorder: an fMRI study.

  Journal of psychiatric research 20100301

• Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the Japanese population.

  Neuromolecular medicine 20100301

• The use of antidepressants in clinical practice: focus on agomelatine.

  Human psychopharmacology 20100301

• Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301

• Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure.

  British journal of clinical pharmacology 20100301

• Fluvoxamine and sigma-1 receptor agonists dehydroepiandrosterone (DHEA)-sulfate induces the Ser473-phosphorylation of Akt-1 in PC12 cells.

  Life sciences 20100227

• Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.

  Journal of affective disorders 20100201

• Cytochrome P450 2C19 inhibitory activity of common berry constituents.

  Phytotherapy research : PTR 20100201

• Brugada syndrome ECG provoked by the selective serotonin reuptake inhibitor fluvoxamine.

  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20100201

• Use of aripiprazole in clozapine induced enuresis: report of two cases.

  Journal of Korean medical science 20100201

• Gestational exposure to the organophosphate chlorpyrifos alters social-emotional behaviour and impairs responsiveness to the serotonin transporter inhibitor fluvoxamine in mice.

  Psychopharmacology 20100101

• Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.

  Neuropsychobiology 20100101

• Effects of cigarette smoking and cytochrome P450 2D6 genotype on fluvoxamine concentration in plasma of Japanese patients.

  Biological & pharmaceutical bulletin 20100101

• Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease.

  Annals of general psychiatry 20100101

• Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.

  PloS one 20100101

• Fluvoxamine versus other anti-depressive agents for depression.

  The Cochrane database of systematic reviews 20100101

• Behavioral despair during a water maze learning task in mice.

  Experimental animals 20100101

• Inhibitory action of fluvoxamine on Kv1.5 currents.

  Biological & pharmaceutical bulletin 20100101

• Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.

  Comprehensive psychiatry 20100101

• No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression.

  Psychotherapy and psychosomatics 20100101

• Ecchymoses as an adverse effect of fluvoxamine treatment in an adolescent girl.

  General hospital psychiatry 20100101

• Aripiprazole as an augmentation agent in treatment-resistant body dysmorphic disorder.

  Clinical drug investigation 20100101

• [Selective serotonin reuptake inhibitors and mammary pathologies].

  Voprosy onkologii 20100101

• Pharmacologically distinctive behaviors other than burying marbles during the marble burying test in mice.

  Pharmacology 20100101

• Onset of clinical effects and plasma concentration of fluvoxamine in Japanese patients.

  Biological & pharmaceutical bulletin 20100101

• Influence of antidepressant drugs on chlorpromazine metabolism in human liver--an in vitro study.

  Pharmacological reports : PR 20100101

• Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?

  CNS & neurological disorders drug targets 20091201

• Photosensitivity associated with selective serotonin reuptake inhibitors.

  Clinical and experimental dermatology 20091201

• Prevalence of depression in a general hospital in Izhevsk, Russia.

  Nordic journal of psychiatry 20091101

• Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

  Nature chemical biology 20091001

• Trichotilliomania responding to low-dose fluvoxamine.

  Psychiatry and clinical neurosciences 20091001

• In vitro and in vivo evaluation of the inhibition potential of risperidone toward clozapine biotransformation.

  British journal of clinical pharmacology 20091001

• Observation of QTc prolongation in an adolescent girl during fluvoxamine pharmacotherapy.

  Journal of child and adolescent psychopharmacology 20091001

• Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.

  The international journal of neuropsychopharmacology 20090901

• The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats.

  Behavioural pharmacology 20090901

• Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship.

  Central nervous system agents in medicinal chemistry 20090901

• Last observation carried forward: a crystal ball?

  Journal of biopharmaceutical statistics 20090901

• Behavioral effects of four antidepressants on an ischemic rat model of emotional disturbances.

  Behavioural brain research 20090812

• Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.

  Progress in neuro-psychopharmacology & biological psychiatry 20090801

• ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.

  Journal of clinical psychopharmacology 20090801

• Musical obsession: repeated auditory imagery of a cell phone ring tone.

  Psychiatry and clinical neurosciences 20090801

• Effects of Psilocybe argentipes on marble-burying behavior in mice.

  Bioscience, biotechnology, and biochemistry 20090801

• Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.

  Journal of psychopharmacology (Oxford, England) 20090701

• Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine-alprazolam interaction in patients with psychosomatic disease.

  European journal of clinical pharmacology 20090701

• Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.

  Neuroscience research 20090701

• A transition model for ordinal response data with random dropout: an application to the fluvoxamine data.

  Journal of biopharmaceutical statistics 20090701

• Changes of functional MRI findings in a patient whose pathological gambling improved with fluvoxamine.

  Yonsei medical journal 20090630

• A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20090601

• [Pharmaceutical treatment of binge eating disorder].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20090601

• 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.

  Psychiatry research 20090515

• Spectrofluorimetric determination of fluvoxamine in dosage forms and plasma via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole.

  Journal of fluorescence 20090501

• Fluvoxamine exerts anorexic effect in 5-HT2C receptor mutant mice with heterozygous mutation of beta-endorphin gene.

  The international journal of neuropsychopharmacology 20090501

• Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.

  Biological psychiatry 20090501

• Spectrophotometric study for the reaction between fluvoxamine and 1,2-naphthoquinone-4-sulphonate: Kinetic, mechanism and use for determination of fluvoxamine in its dosage forms.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20090501

• Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.

  The American journal of psychiatry 20090501

• Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2.

  Neuroscience letters 20090501

• Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression.

  Journal of pharmacological sciences 20090501

• Pharmacological REM sleep suppression paradoxically improves rather than impairs skill memory.

  Nature neuroscience 20090401

• Musical obsession or pseudohallucination: electrophysiological standpoint.

  Psychiatry and clinical neurosciences 20090401

• Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.

  Journal of child and adolescent psychopharmacology 20090401

• Invivo antioxidant status: a putative target of antidepressant action.

  Progress in neuro-psychopharmacology & biological psychiatry 20090317

• Delirium due to a drug-drug interaction of lithium and an NSAID.

  The journal of nutrition, health & aging 20090301

• Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090201

• A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Interaction between SERTPR and stressful life events on response to antidepressant treatment.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090101

• Intracerebroventricular fluvoxamine administration inhibited pain behavior but increased Fos expression in affective pain pathways.

  Pharmacology, biochemistry, and behavior 20090101

• Effects of intrathecal administration of newer antidepressants on mechanical allodynia in rat models of neuropathic pain.

  Neuroscience research 20090101

• Hyperpigmentation with amisulpride.

  The Australian and New Zealand journal of psychiatry 20090101

• Severe eating disorder in a 28-year-old man with William's syndrome.

  The American journal of psychiatry 20090101

• Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.

  Acta dermato-venereologica 20090101

• Tiagabine augmentation to fluvoxamine-risperidone combination in the treatment of obsessive-compulsive disorder.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Pharmacologic treatment for the core deficits and associated symptoms of autism in children.

  Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 20090101

• CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients.

  Neuromolecular medicine 20090101

• Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief.

  Molecular pain 20090101

• Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue.

  BMC gastroenterology 20090101

• Fluvoxamine in the treatment of corticosteroid-induced obsessive-compulsive disorder.

  Clinical neuropharmacology 20090101

• Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.

  Neuropsychobiology 20090101

• Effective treatment with low-dose fluvoxamine for obsessive-compulsive disorder after neurosurgery: a case report.

  Clinical neuropharmacology 20090101

• Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors.

  Annals of general psychiatry 20090101

• [SSRI antidepressants and negative schizophrenic symptoms: differences between paroxetine and fluvoxamine in patients treated with olanzapine].

  Rivista di psichiatria 20090101

• Automated analysis of fluvoxamine in rat plasma using a column-switching system and ion-pair high-performance liquid chromatography.

  Biomedical chromatography : BMC 20081201

• Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons.

  Neuropharmacology 20081201

• Kinetic and thermodynamic assessment of binding of serotonin transporter inhibitors.

  The Journal of pharmacology and experimental therapeutics 20081201

• Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20081201

• Dose-dependent effect of the CYP2D6 genotype on the steady-state fluvoxamine concentration.

  Therapeutic drug monitoring 20081201

• Reinforcement magnitude modulation of rate-dependent effects of fluvoxamine and desipramine in the rat.

  Behavioural pharmacology 20081201

• Fluvoxamine inhibits weight gain and food intake in food restricted hyperphagic Wistar rats.

  Biological & pharmaceutical bulletin 20081201

• Nicotine (NC)-induced 'depressive' behavioral symptoms and effects of antidepressants including cannabinoids (CBs).

  The Journal of toxicological sciences 20081201

• Controlled-release fluvoxamine in obsessive-compulsive disorder and social phobia.

  Drugs of today (Barcelona, Spain : 1998) 20081201

• Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats.

  Canadian journal of physiology and pharmacology 20081101

• Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.

  Child and adolescent psychiatric clinics of North America 20081001

• Pharmacokinetic interaction between tandospirone and fluvoxamine in the rat contextual conditioned fear stress model and its functional consequence: Involvement of cytochrome P450 3A4.

  Psychiatry and clinical neurosciences 20081001

• Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding.

  European journal of pharmacology 20080911

• Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.

  Journal of pharmaceutical and biomedical analysis 20080910

• Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise.

  Psychopharmacology 20080801

• Some selective serotonin reuptake inhibitors inhibit dynamin I guanosine triphosphatase (GTPase).

  Biological & pharmaceutical bulletin 20080801

• In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions.

  Basic & clinical pharmacology & toxicology 20080801

• Potentiation of morphine-induced conditioned place preference with concurrent use of amantadine and fluvoxamine by the intraperitoneal and intracerebroventricular injection in rat.

  Behavioural brain research 20080719

• The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects.

  European journal of clinical pharmacology 20080701

• Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex.

  British journal of pharmacology 20080701

• Asperger's syndrome: from hiding to thriving.

  The Nurse practitioner 20080701

• Extended-release fluvoxamine (Luvox CR).

  The Medical letter on drugs and therapeutics 20080630

• Additive effects of combined application of multiple hERG blockers.

  Journal of cardiovascular pharmacology 20080601

• Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression.

  Journal of clinical psychopharmacology 20080601

• Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patients.

  Psychiatry and clinical neurosciences 20080601

• Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20080515

• Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.

  Progress in neuro-psychopharmacology & biological psychiatry 20080515

• Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers.

  European journal of clinical pharmacology 20080501

• The role of RNA editing of the serotonin 2C receptor in a rat model of oro-facial neuropathic pain.

  The European journal of neuroscience 20080501

• Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.

  Obstetrics and gynecology 20080501

• Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat.

  Pharmaceutical research 20080401

• Patient satisfaction with antidepressants: an Internet-based study.

  Journal of affective disorders 20080401

• Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat.

  American journal of physiology. Heart and circulatory physiology 20080401

• Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.

  Journal of clinical pharmacy and therapeutics 20080401

• Quality assessment of fluoxetine and fluvoxamine pharmaceutical formulations purchased in different countries or via the Internet by 19F and 2D DOSY 1H NMR.

  Journal of pharmaceutical and biomedical analysis 20080313

• Mechanistic model for the acute effect of fluvoxamine on 5-HT and 5-HIAA concentrations in rat frontal cortex.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20080303

• Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder.

  Sleep medicine 20080301

• Influence of negative cognition on the parental bonding instrument (PBI) in patients with major depression.

  The Journal of nervous and mental disease 20080301

• Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.

  Biological psychiatry 20080215

• Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.

  The journal of sexual medicine 20080201

• Reinforcement magnitude modulates the rate-dependent effects of fluvoxamine and desipramine on fixed-interval responding in the pigeon.

  Behavioural pharmacology 20080201

• A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients.

  International journal of clinical practice 20080201

• Shortened protocol in practical [11C]SA4503-PET studies for sigma1 receptor quantification.

  Annals of nuclear medicine 20080201

• Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice.

  European journal of pharmacology 20080128

• Antidepressant drugs for narcolepsy.

  The Cochrane database of systematic reviews 20080123

• An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones.

  European journal of pharmacology 20080114

• Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design.

  Protein and peptide letters 20080101

• In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine.

  Clinical pharmacokinetics 20080101

• [Psychopharmacological treatment and quality of life in obsessive compulsive disorder].

  Turk psikiyatri dergisi = Turkish journal of psychiatry 20080101

• [Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101

• Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials.

  General hospital psychiatry 20080101

• Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.

  PloS one 20080101

• Enzyme inhibition and induction in liver disease.

  Current clinical pharmacology 20080101

• Outcome of additional behaviour therapy including treatment discontinuation for fluvoxamine non-responders with obsessive-compulsive disorder.

  Psychotherapy and psychosomatics 20080101

• Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministration.

  Clinical neuropharmacology 20080101

• [Additional treatment in chronic pain syndrome due to hip and knee arthritis with the selective serotonin reuptake inhibitor fluvoxamine (Fevarin].

  Zeitschrift fur Orthopadie und Unfallchirurgie 20080101

• 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.

  Journal of clinical psychopharmacology 20071201

• Effects of the serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran on marble burying behavior in mice.

  Biological & pharmaceutical bulletin 20071201

• Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia.

  Psychiatry and clinical neurosciences 20071201

• Use of isolated hepatocyte preparations for cytochrome P450 inhibition studies: comparison with microsomes for Ki determination.

  Drug metabolism and disposition: the biological fate of chemicals 20071101

• Pharmacokinetic-pharmacodynamic modeling of the effect of fluvoxamine on p-chloroamphetamine-induced behavior.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20071101

• Use of medication in children with psychiatric disorders.

  Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association 20071101

• [Compulsive buying: psychological and biological treatment].

  L'Encephale 20071101

• High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503.

  Biological psychiatry 20071015

• Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors.

  The international journal of neuropsychopharmacology 20071001

• Gene expression changes in peripheral mononuclear cells from schizophrenic patients treated with a combination of antipsychotic with fluvoxamine.

  Progress in neuro-psychopharmacology & biological psychiatry 20071001

• Rapid and sensitive bioanalytical method for measurement of fluvoxamine in human serum using 4-chloro-7-nitrobenzofurazan as pre-column derivatization agent: application to a human pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071001

• Quetiapine and drug interactions: evidence from a routine therapeutic drug monitoring service.

  The Journal of clinical psychiatry 20071001

• Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.

  The Journal of clinical psychiatry 20071001

• [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].

  L'Encephale 20071001

• Predictors of course in obsessive-compulsive disorder: logistic regression versus Cox regression for recurrent events.

  Acta psychiatrica Scandinavica 20070901

• Stalking and Huntington's disease: a neurobiological link?

  Journal of forensic sciences 20070901

• [Review of pharmacological efficacies and side effects of antidepressants].

  Nihon rinsho. Japanese journal of clinical medicine 20070901

• Clinical prediction of antidepressant response in mood disorders: linear multivariate vs. neural network models.

  Psychiatry research 20070830

• Violent dreaming and antidepressant drugs: or how paroxetine made me dream that I was fighting Saddam Hussein.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20070815

• The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.

  Journal of psychopharmacology (Oxford, England) 20070801

• Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction.

  Drug metabolism and disposition: the biological fate of chemicals 20070801

• Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients.

  Psychiatry and clinical neurosciences 20070801

• Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa.

  Psychiatry and clinical neurosciences 20070801

• Antidepressant response in the elderly.

  Psychiatry research 20070730

• Enhanced long-term synaptic depression in an animal model of depression.

  Biological psychiatry 20070701

• Timolol metabolism in human liver microsomes is mediated principally by CYP2D6.

  Drug metabolism and disposition: the biological fate of chemicals 20070701

• Role of 5-HT receptor antagonists in mediating intracavernous pressure response induced by fluvoxamine in conscious rats.

  The journal of sexual medicine 20070701

• Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.

  Progress in neuro-psychopharmacology & biological psychiatry 20070630

• Piloerection induced by replacing fluvoxamine with milnacipran.

  British journal of clinical pharmacology 20070601

• Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.

  European journal of pharmacology 20070601

• Psychotic disorder in a patient with central and extrapontine myelinolysis.

  Psychiatry and clinical neurosciences 20070601

• Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases.

  Journal of child and adolescent psychopharmacology 20070601

• Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae.

  Ecotoxicology and environmental safety 20070501

• Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice.

  Journal of neurochemistry 20070501

• Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats.

  Psychopharmacology 20070501

• The selective serotonin reuptake inhibitor fluvoxamine suppresses post-feeding hyperactivity induced by food restriction in rats.

  Pharmacology, biochemistry, and behavior 20070501

• EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin.

  Pharmacopsychiatry 20070501

• 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design.

  Biochemical and biophysical research communications 20070406

• Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study.

  The international journal of neuropsychopharmacology 20070401

• Time-dependent clearance decrements of fluvoxamine in depressed inpatients: a clinical evaluation.

  Journal of clinical psychopharmacology 20070401

• Dose-dependent effects of the 3435 C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine in psychiatric patients.

  Therapeutic drug monitoring 20070401

• Remarkable antidepressant augmentation effect of raloxifene, a selective estrogen receptor modulator, in a partial responder to fluvoxamine: a case report.

  The Journal of clinical psychiatry 20070401

• HPLC method for the determination of fluvoxamine in human plasma and urine for application to pharmacokinetic studies.

  Journal of pharmaceutical and biomedical analysis 20070312

• Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070301

• A neural network model for combining clinical predictors of antidepressant response in mood disorders.

  Journal of affective disorders 20070301

• Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran.

  Naunyn-Schmiedeberg's archives of pharmacology 20070301

• Benefits of cognitive-behavioural therapy for children and youth with obsessive-compulsive disorder: re-examination of the evidence.

  The Australian and New Zealand journal of psychiatry 20070301

• Latent-variable models for longitudinal data with bivariate ordinal outcomes.

  Statistics in medicine 20070227

• Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.

  Psychopharmacology 20070201

• Fluvoxamine in the treatment of late-life depression: how much we know coming from randomized controlled trials: comment on article by Dr Rossini and colleagues.

  Journal of clinical psychopharmacology 20070201

• Sleep-related problems among children and adolescents with anxiety disorders.

  Journal of the American Academy of Child and Adolescent Psychiatry 20070201

• Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.

  Journal of psychosomatic research 20070201

• Identification of human cytochrome P450 enzymes involved in the major metabolic pathway of fluvoxamine.

  Xenobiotica; the fate of foreign compounds in biological systems 20070201

• Re-evaluation of tacrine hepatotoxicity using gel entrapped hepatocytes.

  Toxicology letters 20070130

• Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.

  Psychiatry research 20070115

• Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101

• Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat.

  Psychopharmacology 20070101

• Population pharmacokinetic model of fluvoxamine in rats: utility for application in animal behavioral studies.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20070101

• Spectrofluorometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamine.

  Journal of AOAC International 20070101

• [Methylphenidate augmentation of fluvoxamine for treatment-resistant depression: a case report and review literature].

  Turk psikiyatri dergisi = Turkish journal of psychiatry 20070101

• Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment.

  Journal of neural transmission (Vienna, Austria : 1996) 20070101

• Effect of fluvoxamine on the pharmacokinetics of roflumilast and roflumilast N-oxide.

  Clinical pharmacokinetics 20070101

• Motivation to change as a predictor of treatment response in obsessive compulsive disorder.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101

• Status epilepticus following intentional overdose of fluvoxamine: a case report with serum fluvoxamine concentration.

  Clinical toxicology (Philadelphia, Pa.) 20070101

• Effects of fluvoxamine on anxiety, depression, and subjective handicaps of chronic dizziness patients with or without neuro-otologic diseases.

  Journal of vestibular research : equilibrium & orientation 20070101

• Compulsive buying and binge eating disorder--a case vignettes.

  Progress in neuro-psychopharmacology & biological psychiatry 20061230

• Possible involvement of opioidergic systems in the antinociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice.

  European journal of pharmacology 20061215

• Decision-making functioning as a predictor of treatment outcome in anorexia nervosa.

  Psychiatry research 20061207

• The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects.

  British journal of clinical pharmacology 20061201

• Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction.

  International psychogeriatrics 20061201

• Lack of enhanced effect of antipsychotics combined with fluvoxamine on acetylcholine release in rat prefrontal cortex.

  Journal of pharmacological sciences 20061201

• A preliminary study on the interaction of fluvoxamine and adenosine receptor on isolated Guinea-pig atria.

  The International journal of neuroscience 20061201

• Effects of fluvoxamine on behavioral and psychological symptoms of dementia in Alzheimer's disease: a report of three cases.

  Fukushima journal of medical science 20061201

• Trichotillomania: a treatment overview.

  The Journal of practical nursing 20061201

• Antidepressants enhance the antinociceptive effects of carbamazepine in the acetic acid-induced writhing test in mice.

  European journal of pharmacology 20061121

• Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061107

• Phenytoin as an augmentation for SSRI failures: a small controlled study.

  Journal of affective disorders 20061101

• Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.

  Behavioural pharmacology 20061101

• Role of serotonin type 1A receptors in fluvoxamine-induced inhibition of marble-burying behavior in mice.

  Behavioural pharmacology 20061101

• Fluvoxamine effects on concurrent ethanol- and food-maintained behaviors.

  Experimental and clinical psychopharmacology 20061101

• [Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20061101

• Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression.

  Journal of affective disorders 20061001

• Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve.

  European journal of clinical pharmacology 20061001

• Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.

  Journal of clinical psychopharmacology 20061001

• Somatic symptoms in children and adolescents with anxiety disorders.

  Journal of the American Academy of Child and Adolescent Psychiatry 20061001

• [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].

  Presse medicale (Paris, France : 1983) 20061001

• [Is the suicidal risk assessment scale RSD of predictive value?].

  L'Encephale 20061001

• Hippocampal synapsin I, growth-associated protein-43, and microtubule-associated protein-2 immunoreactivity in learned helplessness rats and antidepressant-treated rats.

  Neuroscience 20060901

• Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A/2C receptors.

  Neuropharmacology 20060901

• Effects of chronic fluvoxamine on ethanol- and food-maintained behaviors.

  Life sciences 20060822

• From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060801

• Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants.

  Psychiatric genetics 20060801

• Poor correlation between 6beta-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity.

  British journal of clinical pharmacology 20060801

• Fluvoxamine-induced bullous eruption mimicking hand-foot syndrome and intertrigo-like eruption: rare cutaneous presentations and elusive pathogenesis.

  Journal of the American Academy of Dermatology 20060801

• Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine.

  Basic & clinical pharmacology & toxicology 20060801

• [Drug interaction of fluvoxamine, a selective serotonin reuptake inhibitor].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20060801

• Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060614

• The effect of chronic co-administration of fluvoxamine and haloperidol compared to clozapine on the GABA system in the rat frontal cortex.

  The international journal of neuropsychopharmacology 20060601

• Hypersalivation induced by olanzapine with fluvoxamine.

  Progress in neuro-psychopharmacology & biological psychiatry 20060601

• Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.

  The Psychiatric clinics of North America 20060601

• Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.

  Psychiatry and clinical neurosciences 20060601

• Effects of caffeine on the kinetics of fluvoxamine and its major metabolite in plasma after a single oral dose of the drug.

  Therapeutic drug monitoring 20060601

• Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve.

  Therapeutic drug monitoring 20060601

• [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].

  No to shinkei = Brain and nerve 20060601

• Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.

  Fukushima journal of medical science 20060601

• Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway.

  Journal of chromatography. A 20060519

• Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release.

  The Journal of biological chemistry 20060505

• Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: the role of clinical, psychosocial and genetic variables.

  Progress in neuro-psychopharmacology & biological psychiatry 20060501

• The spermicidal and antitrichomonas activities of SSRI antidepressants.

  Bioorganic & medicinal chemistry letters 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.

  Clinical pharmacology and therapeutics 20060501

• Quetiapine-fluvoxamine combination during pregnancy and while breastfeeding.

  Archives of women's mental health 20060501

• Dramatic remission of treatment-resistant depression after the cessation of tricyclic antidepressants.

  Pharmacopsychiatry 20060501

• Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060401

• T3 augmentation of SSRI resistant depression.

  Journal of affective disorders 20060401

• Tolerability and safety of fluvoxamine and other antidepressants.

  International journal of clinical practice 20060401

• Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial.

  Journal of clinical psychopharmacology 20060401

• Time course of in vivo 5-HTT transporter occupancy by fluvoxamine.

  Journal of clinical psychopharmacology 20060401

• Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.

  British journal of clinical pharmacology 20060301

• Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.

  European journal of pharmacology 20060227

• Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.

  Journal of affective disorders 20060201

• Dopamine release in human neocortical slices: characterization of inhibitory autoreceptors and of nicotinic acetylcholine receptor-evoked release.

  Brain research bulletin 20060130

• Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors.

  Brain research 20060105

• Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations.

  Progress in neuro-psychopharmacology & biological psychiatry 20060101

• Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060101

• Serotonin syndrome induced by fluvoxamine and oxycodone.

  The Annals of pharmacotherapy 20060101

• N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.

  Psychopharmacology 20060101

• Cognitive behavioral therapy versus psychosurgery for refractory obsessive-compulsive disorder.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• Blindness of clinical evaluators, parents, and children in a placebo-controlled trial of fluvoxamine.

  Journal of child and adolescent psychopharmacology 20060101

• [Effects of behavior therapy applied to obsessive-compulsive disorders--comparison with drug therapy].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20060101

• Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.

  Neuropsychobiology 20060101

• Co-administration of ramelton and fluvoxamine to increase levels of interleukin-2.

  Medical hypotheses 20060101

• [Molecular pharmacogenetic study on antipsychotic-drug therapy responders with depression or schizophrenia].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20060101

• [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].

  Tijdschrift voor psychiatrie 20060101

• [A double-blind controlled study of the efficacy and acceptability of tianeptine in comparison with fluvoxamine in the treatment of depressed alcoholic patients].

  Psychiatria polska 20060101

• [Stereotyped behaviors and compulsive complaints of pain improved by fluvoxamine in two cases of frontotemporal dementia].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20060101

• Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients.

  Neuropsychobiology 20060101

• Prenatal bupropion exposure enhances the cocaine reward and stress susceptibility in adult mice.

  The Chinese journal of physiology 20051231

• An appraisal of methods for the analysis of longitudinal categorical data with MAR drop-outs.

  Statistics in medicine 20051215

• Determination of fluvoxamine in rat plasma by HPLC with pre-column derivatization and fluorescence detection using 4-fluoro-7-nitro-2,1,3-benzoxadiazole.

  Biomedical chromatography : BMC 20051201

• No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20051201

• Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia.

  Pharmacological research 20051201

• An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.

  Journal of clinical psychopharmacology 20051201

• Fluvoxamine affects sildenafil kinetics and dynamics.

  Journal of clinical psychopharmacology 20051201

• Comments on article by Albers et al: 'Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy'.

  Journal of clinical psychopharmacology 20051201

• Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer.

  Journal of the American Academy of Child and Adolescent Psychiatry 20051201

• Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder.

  Expert opinion on pharmacotherapy 20051201

• Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.

  International journal of clinical practice 20051201

• Effect of paroxetine on marble-burying behavior in mice.

  Methods and findings in experimental and clinical pharmacology 20051201

• Acute effects of clozapine-fluvoxamine combination.

  Schizophrenia research 20051115

• Chronopharmacological study of antidepressants in forced swimming test of mice.

  The Journal of pharmacology and experimental therapeutics 20051101

• Fluvoxamine and desipramine on fixed-ratio responding: effects of reinforcement magnitude.

  Behavioural pharmacology 20051101

• Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics.

  British journal of clinical pharmacology 20051101

• Approach to novel functional foods for stress control 4. Regulation of serotonin transporter by food factors.

  The journal of medical investigation : JMI 20051101

• Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up.

  The Journal of clinical psychiatry 20051101

• Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice.

  Brain research 20051012

• Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study.

  NeuroImage 20051001

• Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.

  Journal of clinical psychopharmacology 20051001

• Possible antipsychotic effect of fluvoxamine.

  CNS spectrums 20051001

• Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice.

  European journal of pharmacology 20050927

• (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.

  The Journal of pharmacology and experimental therapeutics 20050901

• Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed?

  Psychopharmacology 20050901

• Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders.

  Journal of psychopharmacology (Oxford, England) 20050901

• Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism.

  American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20050805

• Serotonin and its antidepressant-sensitive transport in mouse cumulus-oocyte complexes and early embryos.

  Biology of reproduction 20050801

• The effect of fluvoxamine on ouabain-induced arrhythmia in isolated guinea-pig atria.

  Pharmacological research 20050801

• Electroanalytical study of fluvoxamine.

  Analytical and bioanalytical chemistry 20050801

• Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors.

  Regulatory toxicology and pharmacology : RTP 20050801

• Effects of a 5-HT7 receptor antagonist DR4004 on the exploratory behavior in a novel environment and on brain monoamine dynamics in mice.

  European journal of pharmacology 20050725

• Antidepressant drugs for narcolepsy.

  The Cochrane database of systematic reviews 20050720

• Effects of fluvoxamine on a multiple schedule of ethanol- and food-maintained behavior in two rat strains.

  Psychopharmacology 20050701

• Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.

  British journal of clinical pharmacology 20050701

• Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.

  Analytical and bioanalytical chemistry 20050701

• Interaction study between enoxacin and fluvoxamine.

  Therapeutic drug monitoring 20050601

• Toxicity with selective serotonin reuptake inhibitors.

  The American journal of psychiatry 20050601

• Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.

  Journal of autism and developmental disorders 20050601

• Oniomania--successful treatment with fluvoxamine and cognitive-behavioral psychotherapy.

  Psychiatria Danubina 20050601

• Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.

  Psychopharmacology 20050501

• Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.

  International clinical psychopharmacology 20050501

• Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050501

• Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.

  Journal of the American Academy of Child and Adolescent Psychiatry 20050501

• The effect of erythromycin and fluvoxamine on the pharmacokinetics of intravenous lidocaine.

  Anesthesia and analgesia 20050501

• Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study.

  Biological psychiatry 20050501

• Severe diurnal somnolence induced by fluvoxamine-lithium combination.

  Pharmacopsychiatry 20050501

• The difference between the formal and the functional dose: the case of the patient on thioridazine and fluvoxamine.

  Journal of psychiatric practice 20050501

• AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist.

  Brain research 20050425

• Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study.

  Biological psychiatry 20050415

• Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy.

  Journal of clinical psychopharmacology 20050401

• Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies.

  The journal of obstetrics and gynaecology research 20050401

• Photo-isomerization of fluvoxamine in aqueous solutions.

  Journal of pharmaceutical and biomedical analysis 20050401

• Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine.

  The American journal of psychiatry 20050401

• Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.

  European archives of psychiatry and clinical neuroscience 20050401

• Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs.

  American journal of physiology. Endocrinology and metabolism 20050301

• Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.

  British journal of pharmacology 20050301

• Improvement of dry mouth by replacing paroxetine with fluvoxamine.

  The Annals of pharmacotherapy 20050301

• Effects of fluvoxamine on levels of dopamine, serotonin, and their metabolites in the hippocampus elicited by isolation housing and novelty stress in adult rats.

  The International journal of neuroscience 20050301

• Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment.

  Psychiatry research 20050227

• Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine.

  Psychiatry research 20050227

• Determination of fluvoxamine and its metabolite fluvoxamino acid by liquid-liquid extraction and column-switching high-performance liquid chromatography.

  Journal of pharmaceutical and biomedical analysis 20050207

• A sensitive HPLC method for the determination of fluoxetine and norfluoxetine in human plasma with fluorescence detection.

  Therapeutic drug monitoring 20050201

• Nature, assessment, and treatment of generalized anxiety disorder in children.

  Pediatric annals 20050201

• Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice.

  Psychopharmacology 20050101

• Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050101

• The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model.

  Drug metabolism and disposition: the biological fate of chemicals 20050101

• Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050101

• A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.

  Pharmacopsychiatry 20050101

• Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.

  Clinical neuropharmacology 20050101

• Family-oriented rehabilitation for unexplained chronic pain.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050101

• Fluvoxamine induced complex partial seizure in the treatment of bulimia nervosa.

  General hospital psychiatry 20050101

• Pharmacological treatments of pathological gambling.

  Journal of gambling studies 20050101

• A randomized controlled trial of Japanese patients with obsessive-compulsive disorder--effectiveness of behavior therapy and fluvoxamine.

  Psychotherapy and psychosomatics 20050101

• [Case of obsessive-compulsive disorder associated with neuroleptics-induced deficit syndrome (NIDS): successfully treated by discontinuation of neuroleptics followed by SSRI].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20050101

• Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial.

  Advances in therapy 20050101

• Antidepressant apathy syndrome.

  Perspectives in psychiatric care 20050101

• Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).

  Journal of gambling studies 20050101

• Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

  The Journal of neuropsychiatry and clinical neurosciences 20050101

• Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs.

  American journal of physiology. Endocrinology and metabolism 20041201

• The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings.

  The international journal of neuropsychopharmacology 20041201

• The advantages of choosing antiobsessive therapy according to decision-making functioning.

  Journal of clinical psychopharmacology 20041201

• Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia.

  Journal of clinical pharmacology 20041201

• Multiple-dose pharmacokinetics of fluvoxamine in children and adolescents.

  Journal of the American Academy of Child and Adolescent Psychiatry 20041201

• Effects of concomitant fluvoxamine on the plasma concentration of etizolam in Japanese psychiatric patients: wide interindividual variation in the drug interaction.

  Therapeutic drug monitoring 20041201

• Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.

  Archives of general psychiatry 20041201

• Characterization of the anxiolytic-like effects of fluvoxamine, milnacipran and risperidone in mice using the conditioned fear stress paradigm.

  European journal of pharmacology 20041103

• Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine.

  Psychopharmacology 20041101

• Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes.

  Journal of clinical pharmacology 20041101

• Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression.

  European psychiatry : the journal of the Association of European Psychiatrists 20041101

• Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.

  The American journal of psychiatry 20041101

• Beta-arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain.

  The American journal of psychiatry 20041101

• Drug interaction of tizanidine and fluvoxamine.

  Clinical pharmacology and therapeutics 20041101

• In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.

  Life sciences 20041029

• A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.

  Psychopharmacology 20041001

• Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.

  Journal of clinical psychopharmacology 20041001

• Fluvoxamine and graded psychotherapy in the treatment of bulimia nervosa: a randomized, double-blind, placebo-controlled, multicenter study of short-term and long-term pharmacotherapy combined with a stepped care approach to psychotherapy.

  Journal of clinical psychopharmacology 20041001

• Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia.

  Expert opinion on pharmacotherapy 20041001

• Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.

  The Journal of clinical psychiatry 20041001

• [Case report of pentazocine dependence from a standpoint of the cognitive therapy].

  Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20041001

• Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit.

  Psychological medicine 20041001

• Depression in general clinical practice.

  Journal of the Indian Medical Association 20041001

• Treating functional impairment of autism with selective serotonin-reuptake inhibitors.

  The Annals of pharmacotherapy 20040901

• CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20040901

• Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates.

  Journal of psychopharmacology (Oxford, England) 20040901

• Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia.

  Environmental toxicology and chemistry 20040901

• Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.

  International journal of urology : official journal of the Japanese Urological Association 20040901

• [Two cases of adult Down syndrome treated with selective serotonin re-uptake inhibitor for behavior disorders].

  No to hattatsu = Brain and development 20040901

• Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders.

  American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20040815

• Ephedra alkaloids and brief relapse in EMDR-treated obsessive compulsive disorder.

  Acta psychiatrica Scandinavica 20040801

• Olanzapine plus fluvoxamine and olanzapine alone for the treatment of an acute exacerbation of schizophrenia.

  Psychiatry and clinical neurosciences 20040801

• Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.

  Pharmacology, biochemistry, and behavior 20040801

• Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age.

  Human psychopharmacology 20040801

• The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteers.

  Journal of clinical pharmacology 20040701

• [Analysis and its application for prevention of side-effects of drugs and for evaluation of drug responsiveness].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20040601

• Late onset OCD.

  The Australian and New Zealand journal of psychiatry 20040601

• Neonatal complications after intrauterine exposure to SSRI antidepressants.

  Prescrire international 20040601

• Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature.

  The Kaohsiung journal of medical sciences 20040601

• Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances.

  The Journal of clinical psychiatry 20040601

• Antipsychotic-associated weight gain.

  The Annals of pharmacotherapy 20040501

• Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo.

  Magma (New York, N.Y.) 20040501

• Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature.

  Haematologica 20040501

• 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam.

  Behavioural pharmacology 20040501

• Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology.

  Drug and alcohol dependence 20040409

• Efficacy and pharmacokinetics of fluvoxamine maleate in patients with mild depression undergoing hemodialysis.

  Psychiatry and clinical neurosciences 20040401

• Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes.

  British journal of clinical pharmacology 20040401

• Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.

  Clinical pharmacology and therapeutics 20040401

• Induction of diphenytriazol on cytochrome CYP1A.

  Acta pharmacologica Sinica 20040401

• A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection.

  Journal of analytical toxicology 20040401

• [Postherpetic neuralgia alleviated by an SSRI fluvoxamine: two cases of PHN accompanied with depression were treated with fluvoxamine].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20040401

• [Dysfunction of serotonergic systems in thiamine-deficient diet fed mice: effects of SSRI on abnormality induced by thiamine deficiency].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20040401

• Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder.

  Journal of clinical psychopharmacology 20040401

• Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039.

  Biochemical and biophysical research communications 20040305

• Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin in the mouse hippocampus.

  Neuropharmacology 20040301

• The effects of selective serotonin-reuptake inhibitor on visual evoked potential in rats.

  Journal of pharmacological sciences 20040301

• A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder.

  Journal of clinical psychopharmacology 20040201

• [Effect of concurrent treatment of SSRI on the tyrosine hydroxylase immunoreactivity in the rat locus coeruleus treated with chronic variable stress].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20040201

• Overvalued ideation as a predictor of fluvoxamine response in patients with obsessive-compulsive disorder.

  Psychiatry research 20040130

• Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia.

  Psychopharmacology 20040101

• Serotonin uptake and metabolism by cultured guinea pig airway smooth muscle cells.

  Pulmonary pharmacology & therapeutics 20040101

• Insight in obsessive compulsive disorder and body dysmorphic disorder.

  Comprehensive psychiatry 20040101

• Different effects of selective serotonin reuptake inhibitors on a patient suffering from panic disorder.

  Human psychopharmacology 20040101

• Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients.

  Dementia and geriatric cognitive disorders 20040101

• Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function.

  Clinical pharmacology and therapeutics 20040101

• Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.

  Pharmacopsychiatry 20040101

• Homeopathic remedies as placebo alternatives--verification on the example of treatment of menopause-related vegetative and emotional disturbances.

  Science and engineering ethics 20040101

• The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients.

  The pharmacogenomics journal 20040101

• [Selective serotonin reuptake inhibitors--current knowledge].

  Psychiatria polska 20040101

• Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634].

  BMC gastroenterology 20040101

• [Estimation of therapeutical efficacy of weak variable magnetic fields with low value of induction in patients with depression].

  Psychiatria polska 20040101

• Coexistent hypothyroidism, psychosis, and severe obsessions in an adolescent: a 10-year follow-up.

  Journal of child and adolescent psychopharmacology 20040101

• Fluvoxamine treatment of major depression associated with multiple sclerosis.

  The Journal of neuropsychiatry and clinical neurosciences 20040101

• Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder.

  The Psychiatric quarterly 20040101

• Influence of antidepressant drugs on macrophage cytotoxic activity in rats.

  Polish journal of pharmacology 20040101

• [Review of double-blind studies comparing SSRI and SNRI].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20040101

• Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.

  Journal of medicine 20040101

• In vitro metabolism of zolmitriptan in rat cytochromes induced with beta-naphthoflavone and the interaction between six drugs and zolmitriptan.

  Chemico-biological interactions 20031215

• Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.

  The international journal of neuropsychopharmacology 20031201

• Interaction study between fluvoxamine and quazepam.

  Journal of clinical pharmacology 20031201

• Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression.

  Journal of clinical psychopharmacology 20031201

• Treatment of pathological gambling: a critical review of the literature.

  Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors 20031201

• Relationship between fluvoxamine and stress barometer for nocturnal enuresis.

  Pediatrics international : official journal of the Japan Pediatric Society 20031201

• Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.

  European psychiatry : the journal of the Association of European Psychiatrists 20031201

• Joint regression and association modeling of longitudinal ordinal data.

  Biometrics 20031201

• Interactions of acute morphine with chronic imipramine and fluvoxamine treatment on the antinociceptive effect in arthritic rats.

  Neuroscience letters 20031127

• Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.

  Journal of clinical pharmacology 20031101

• Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons.

  Journal of neurochemistry 20031101

• [Improved method of fluvoxamine synthesis].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20031001

• Metabolism and elimination of quinine in healthy volunteers.

  European journal of clinical pharmacology 20030901

• Successful electroconvulsive therapy in major depression with fluvoxamine-induced bruxism.

  The journal of ECT 20030901

• [Anxiety in school refusal children with indefinite complaints: psychological estimation using State-Trait Anxiety Inventory and therapy by serotonin reuptake inhibitors].

  No to hattatsu = Brain and development 20030901

• Trichotillomania: a review and case report.

  Cutis 20030901

• Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

  Psychopharmacology 20030801

• Re: The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis.

  The Journal of urology 20030801

• Effects of the CYP 2D6 genotype and cigarette smoking on the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.

  Therapeutic drug monitoring 20030801

• Methylphenidate-induced obsessive-compulsive symptoms in an elderly man.

  CNS spectrums 20030801

• Grapefruit juice-fluvoxamine interaction--is it risky or not?

  Journal of clinical psychopharmacology 20030801

• Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.

  Human psychopharmacology 20030801

• Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression.

  Human psychopharmacology 20030801

• Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice.

  Journal of neurochemistry 20030701

• Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine.

  British journal of pharmacology 20030701

• Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.

  British journal of pharmacology 20030701

• Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison.

  Human psychopharmacology 20030701

• [Effect of selective serotonin reuptake inhibitor on the chronic rumination and vomiting of a severely handicapped patient].

  No to hattatsu = Brain and development 20030701

• Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.

  Psychopharmacology 20030601

• A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20030601

• Changes in synaptic properties in cortical-limbic communications induced by repeated treatments with fluvoxamine in rats.

  Journal of pharmacological sciences 20030601

• High-performance liquid chromatographic determination of fluvoxamine and fluvoxamino acid in human plasma.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20030601

• Assessment of safety in pediatric psychopharmacology.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030601

• A local influence approach applied to binary data from a psychiatric study.

  Biometrics 20030601

• [Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].

  MMW Fortschritte der Medizin 20030526

• Fluvoxamine modulates pain sensation and affective processing of pain in human brain.

  Neuroreport 20030506

• Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade.

  Psychopharmacology 20030501

• Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19.

  Drug metabolism and disposition: the biological fate of chemicals 20030501

• Fluvoxamine therapy for fibromyalgia.

  The Journal of rheumatology 20030501

• Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man.

  European journal of clinical pharmacology 20030501

• [Studies on the adverse effects of fluvoxamine treatment in children with autistic disorder: correlation with genetic polymorphism in serotonin related genes].

  No to hattatsu = Brain and development 20030501

• [A five-year-old girl with epilepsy showing forced normalization due to zonisamide].

  No to hattatsu = Brain and development 20030501

• Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder.

  CNS spectrums 20030501

• Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice.

  Pharmacology, biochemistry, and behavior 20030501

• Suitable dose and duration of fluvoxamine administration to treat depression.

  Psychiatry and clinical neurosciences 20030401

• Possible predictors of response to fluvoxamine for depression.

  Human psychopharmacology 20030401

• High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.

  Archives of general psychiatry 20030401

• Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles.

  European journal of clinical pharmacology 20030401

• A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response.

  Archives of women's mental health 20030401

• Study and analytical application of ion-pair formation in the system fluoxetine-pyrocatechol violet and fluvoxamine-pyrocatechol violet.

  Die Pharmazie 20030401

• Assessment of the contributions of CYP3A4 and CYP3A5 in the metabolism of the antipsychotic agent haloperidol to its potentially neurotoxic pyridinium metabolite and effect of antidepressants on the bioactivation pathway.

  Drug metabolism and disposition: the biological fate of chemicals 20030301

• Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.

  Human psychopharmacology 20030301

• The onset and time course of response of negative symptoms to add-on fluvoxamine treatment.

  International clinical psychopharmacology 20030301

• Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens.

  Neuropharmacology 20030301

• Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers.

  Journal of psychiatry & neuroscience : JPN 20030301

• Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.

  Journal of psychopharmacology (Oxford, England) 20030301

• Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).

  British journal of pharmacology 20030301

• [Post-stroke depression].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20030301

• Fluvoxamine-induced hyperglycaemia in a diabetic patient with comorbid depression.

  The international journal of neuropsychopharmacology 20030301

• Serotonergic signaling inhibits hyperalgesia induced by spinal cord damage.

  Brain research 20030214

• Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.

  Psychiatric services (Washington, D.C.) 20030201

• An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex.

  Naunyn-Schmiedeberg's archives of pharmacology 20030201

• Drug-related hyperprolactinemia.

  Prescrire international 20030201

• CYP2D6*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjects.

  European journal of clinical pharmacology 20030201

• Possible involvement of peripheral serotonin 5-HT3 receptors in fluvoxamine-induced emesis in Suncus murinus.

  The Journal of pharmacy and pharmacology 20030201

• Antidepressant response and fluvoxamine plasma concentrations: a pilot study.

  Pharmacy world & science : PWS 20030201

• Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study.

  Journal of autism and developmental disorders 20030201

• Fluvoxamine suppresses the long-term potentiation in the hippocampal CA1 field of anesthetized rats: an effect mediated via 5-HT1A receptors.

  Brain research 20030103

• Fluvoxamine reduces responsiveness of HPA axis in adult female BPD patients with a history of sustained childhood abuse.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101

• Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030101

• Adjunctive fluvoxamine with clozapine.

  The British journal of psychiatry : the journal of mental science 20030101

• [Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder].

  No to hattatsu = Brain and development 20030101

• [Comparative efficacy and tolerance of fluvoxamine and amitriptyline in the treatment of moderate and severe depression in mental hospital].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101

• An open trial of fluvoxamine for hypochondriasis.

  Psychosomatics 20030101

• [Double depression].

  Ryoikibetsu shokogun shirizu 20030101

• [Pharmacokinetics and drug interaction of antidepressants and anti-manic drugs].

  Ryoikibetsu shokogun shirizu 20030101

• [Serotonin syndrome].

  Ryoikibetsu shokogun shirizu 20030101

• [Panic disorder and agoraphobia].

  Ryoikibetsu shokogun shirizu 20030101

• [The treatment of OCD].

  Ryoikibetsu shokogun shirizu 20030101

• [Compulsion(ritual)].

  Ryoikibetsu shokogun shirizu 20030101

• [Eating disorders].

  Ryoikibetsu shokogun shirizu 20030101

• The use of sumatriptan in the treatment of obsessive-compulsive disorder in an adolescent.

  Journal of child and adolescent psychopharmacology 20030101

• Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine.

  Neuropsychobiology 20030101

• [The usage of different antidepressants in therapy of obsessive-compulsive disorders].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101

• Add-on fluvoxamine improves primary negative symptoms: evidence for specificity from response analysis of individual symptoms.

  Schizophrenia bulletin 20030101

• [Obsessive-compulsive disorder in childhood and adolescence].

  Ryoikibetsu shokogun shirizu 20030101

• Effects of fluvoxamine, a selective serotonin re-uptake inhibitor, on serotonin release from the mouse isolated ileum.

  Research communications in molecular pathology and pharmacology 20030101

• Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.

  Brain research 20021220

• Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.

  Biological psychiatry 20021215

• SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder.

  The American journal of psychiatry 20021201

• Fluvoxamine interaction with warfarin.

  The Annals of pharmacotherapy 20021201

• Dosing strategies of clozapine-fluvoxamine cotreatment.

  Journal of clinical psychopharmacology 20021201

• Consultation with the specialist: the central serotonin syndrome: paradigm for psychotherapeutic misadventure.

  Pediatrics in review 20021201

• Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20021201

• Fluvoxamine treatment of a Japanese patient with koro.

  The Journal of clinical psychiatry 20021201

• Antipsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain.

  Neuroscience letters 20021129

• Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine.

  European journal of pharmacology 20021115

• Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021101

• No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20021001

• Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects.

  Journal of clinical psychopharmacology 20021001

• Comments on in vitro and in vivo studies of fluvoxamine-clozapine interaction.

  Journal of clinical psychopharmacology 20021001

• Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine.

  The International journal of neuroscience 20021001

• Changes in synaptic plasticity in the rat hippocampo-medial prefrontal cortex pathway induced by repeated treatments with fluvoxamine.

  Brain research 20020913

• Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression.

  Pharmacopsychiatry 20020901

• A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder.

  The Journal of clinical psychiatry 20020901

• Obsessive-compulsive disorder with non-24-hour sleep-wake syndrome.

  The Journal of clinical psychiatry 20020901

• Photoisomerization of fluvoxamine generates an isomer that has reduced activity on the 5-hydroxytryptamine transporter and does not affect cell proliferation.

  European journal of pharmacology 20020830

• A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine.

  Psychiatry research 20020830

• Serotonin agents in the treatment of acquired brain injury.

  The Journal of head trauma rehabilitation 20020801

• Block of volume-regulated anion channels by selective serotonin reuptake inhibitors.

  Naunyn-Schmiedeberg's archives of pharmacology 20020801

• 24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020801

• Fluvoxamine-clozapine interaction: time-dependent?

  Journal of clinical psychopharmacology 20020801

• Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.

  Psychopharmacology 20020801

• CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.

  Pharmacotherapy 20020801

• An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy.

  The Journal of clinical psychiatry 20020801

• Serum cholesterol level comparison: control subjects, anxiety disorder patients, and obsessive-compulsive disorder patients.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20020801

• Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.

  Psychopharmacology 20020701

• [A case of Klüver-Bucy syndrome after acute encephalopathy treated with selective serotonin reuptake inhibitor (fluvoxamine)].

  No to hattatsu = Brain and development 20020701

• The effect of fluvoxamine and sertraline on the opioid withdrawal syndrome: a combined in vivo cerebral microdialysis and behavioural study.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020601

• Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat.

  Experimental neurology 20020601

• Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.

  The American journal of psychiatry 20020501

• [Treatment with fluvoxamine against self-injury and aggressive behavior in autistic children].

  No to hattatsu = Brain and development 20020501

• The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants.

  Journal of human lactation : official journal of International Lactation Consultant Association 20020501

• Fluvoxamine: safety profile in extensive post-marketing surveillance.

  Pharmacopsychiatry 20020501

• The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.

  European journal of pharmacology 20020329

• Musical hallucinations and deafness: a case report and review of the literature.

  Neuropsychiatry, neuropsychology, and behavioral neurology 20020301

• Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients.

  Medical science monitor : international medical journal of experimental and clinical research 20020301

• The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment.

  Psychopharmacology 20020301

• Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study.

  International clinical psychopharmacology 20020301

• Neurotoxic syndrome associated with risperidone and fluvoxamine.

  The Annals of pharmacotherapy 20020301

• Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19).

  Clinical pharmacology and therapeutics 20020301

• A pilot placebo-controlled study of fluvoxamine for pathological gambling.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20020301

• Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.

  The international journal of neuropsychopharmacology 20020301

• Fluvoxamine augmentation in risperidone-resistant schizophrenia: an open trial.

  Human psychopharmacology 20020301

• Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

  Progress in neuro-psychopharmacology & biological psychiatry 20020201

• Diagnosis at the first episode to differentiate antidepressant treatment responses in patients with mood and anxiety disorders.

  Psychopharmacology 20020201

• Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha(2)-adrenergic receptors in depression.

  Psychiatry research 20020131

• An 8-year-old boy with autism, 1 year later.

  JAMA 20020101

• Interaction between fluvoxamine and cotinine or caffeine.

  Neuropsychobiology 20020101

• Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder.

  Depression and anxiety 20020101

• Spotlight on fluvoxamine in anxiety disorders in children and adolescents.

  CNS drugs 20020101

• The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine.

  Psychopharmacology 20020101

• [A case of fluvoxamine overdose].

  Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology 20020101

• Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia.

  Journal of child and adolescent psychopharmacology 20020101

• Refractory obsessive-compulsive disorder: state-of-the-art treatment.

  The Journal of clinical psychiatry 20020101

• [Evaluation of analgesic action of fluvoxamine compared with efficacy of imipramine and tramadol for treatment of sciatica--open trial].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20020101

• Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.

  The pharmacogenomics journal 20020101

• Delayed recurrent SIADH associated with SSRIs.

  The Annals of pharmacotherapy 20020101

• Comment: neuroleptic malignant syndrome associated with risperidone and fluvoxamine.

  The Annals of pharmacotherapy 20020101

• Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype.

  Drug metabolism and drug interactions 20020101

• [Methods of determination of fluoxetine nad fluvoxamine].

  Psychiatria polska 20020101

• [A case of amyotrophic lateral sclerosis with SIADH and throbbing headache induced by selective serotonin reuptake inhibitor].

  Rinsho shinkeigaku = Clinical neurology 20020101

• CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine.

  Journal of psychiatric research 20020101

• Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.

  Neuropsychobiology 20020101

• Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study.

  Journal of child and adolescent psychopharmacology 20020101

• [Prognostic value of pharmaco-EEG in depression treated with fluvoxamine].

  Psychiatria polska 20020101

• Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.

  Journal of clinical psychopharmacology 20011201

• Abnormalities of thermoregulation induced by fluvoxamine.

  Journal of clinical psychopharmacology 20011201

• Differences between in vitro and in vivo determinations of fluvoxamine-clozapine interaction.

  Journal of clinical psychopharmacology 20011201

• SSRIs associated with behavioral activation and suicidal ideation.

  Journal of the American Academy of Child and Adolescent Psychiatry 20011201

• [Effects of fluvoxamine on both the desired anxiolytic effect and the adverse motor incoordination and amnesia induced by benzodiazepines].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20011201

• Aggravation of glaucoma with fluvoxamine.

  The Annals of pharmacotherapy 20011201

• Comment: serotonin syndrome induced by fluvoxamine and mirtazapine.

  The Annals of pharmacotherapy 20011201

• Successful treatment of steroid-induced depression with low dosage of fluvoxamine.

  The Australian and New Zealand journal of psychiatry 20011201

• No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors.

  Psychiatry research 20011130

• Characteristics of fluvoxamine-induced nausea.

  Psychiatry research 20011130

• Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2.

  Clinical pharmacology and therapeutics 20011101

• Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations.

  The Journal of nervous and mental disease 20011101

• The major fluvoxamine metabolite in urine is formed by CYP2D6.

  European journal of clinical pharmacology 20011101

• Aminophylline reversal of antihypertensive agent toxicity.

  Veterinary and human toxicology 20011001

• Fluvoxamine for postpartum depression.

  The American journal of psychiatry 20011001

• Clinical predictors of drug response in obsessive-compulsive disorder.

  Journal of clinical psychopharmacology 20011001

• Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.

  Clinical pharmacology and therapeutics 20011001

• The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotropin-releasing hormone.

  International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20011001

• Serotonin syndrome induced by fluvoxamine and mirtazapine.

  The Annals of pharmacotherapy 20011001

• Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold.

  The Annals of pharmacotherapy 20011001

• A display of hypomania in a depressed male in response to fluvoxamine.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20011001

• Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test.

  Life sciences 20010907

• The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.

  British journal of pharmacology 20010901

• Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

  Molecular psychiatry 20010901

• Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.

  Biological psychiatry 20010901

• Violent acts associated with fluvoxamine treatment.

  Journal of psychiatry & neuroscience : JPN 20010901

• Taijin kyofusho: a form of social anxiety disorder that responds to serotonin reuptake inhibitors?

  The international journal of neuropsychopharmacology 20010901

• Physical exercise: an adjunctive treatment for panic disorder?

  European psychiatry : the journal of the Association of European Psychiatrists 20010901

• Fluvoxamine for the treatment of anxiety disorders in children and adolescents.

  The New England journal of medicine 20010809

• Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.

  Psychiatry research 20010805

• Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear.

  European journal of pharmacology 20010803

• Fluvoxamine and aggression in mental retardation.

  Psychiatric services (Washington, D.C.) 20010801

• Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service.

  Therapeutic drug monitoring 20010801

• Use of sertraline, paroxetine and fluvoxamine by nursing women.

  The British journal of psychiatry : the journal of mental science 20010801

• More on fluvoxamine and enuresis.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010801

• Is fluvoxamine safe and effective for treating anxiety disorders in children?

  The Journal of family practice 20010801

• [Pharmacokinetics and drug interactions of antidepressive agents].

  Nihon rinsho. Japanese journal of clinical medicine 20010801

• [Early internal treatment of mild depression].

  Nihon rinsho. Japanese journal of clinical medicine 20010801

• [Vascular depression].

  Nihon rinsho. Japanese journal of clinical medicine 20010801

• Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.

  The Journal of clinical psychiatry 20010801

• Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine.

  European journal of clinical pharmacology 20010801

• Mild serotonin syndrome on fluvoxamine.

  The International journal of neuroscience 20010801

• Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine.

  The International journal of eating disorders 20010701

• [Treatment of panic disorder with combination of SSRI and cognitive-behavioral therapy].

  Psychiatrische Praxis 20010701

• Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.

  The Journal of clinical psychiatry 20010701

• [Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder].

  No to hattatsu = Brain and development 20010701

• Fluvoxamine and sleep disturbances in posttraumatic stress disorder.

  Journal of traumatic stress 20010701

• Effects of aging on serotonin transporter availability and its response to fluvoxamine in the living brain: PET study with [(11)C](+)McN5652 and [(11)C](-)McN5652 in conscious monkeys.

  Synapse (New York, N.Y.) 20010601

• Noradrenergic function and clinical outcome in antidepressant pharmacotherapy.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010601

• Effects of fluvoxamine on ethanol-reinforced behavior in the rat.

  The Journal of pharmacology and experimental therapeutics 20010601

• SSRIs and mammoplasia.

  The American journal of psychiatry 20010601

• Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder.

  Journal of clinical psychopharmacology 20010601

• SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects.

  Journal of sleep research 20010601

• Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping.

  Pharmacogenetics 20010601

• Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.

  European journal of pharmacology 20010518

• The luvox debate.

  Time 20010507

• Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine.

  International clinical psychopharmacology 20010501

• A comparative pharmacodynamic study of the arrhythmogenicity of antidepressants, fluvoxamine and imipramine, in guinea pigs.

  Biological & pharmaceutical bulletin 20010501

• Interaction of olanzapine with fluvoxamine.

  Psychopharmacology 20010501

• A case of pathological gambling--its features and mangement.

  Singapore medical journal 20010501

• Drug treatment of anxiety disorders in children.

  The New England journal of medicine 20010426

• Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.

  The New England journal of medicine 20010426

• Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis.

  Journal of clinical psychopharmacology 20010401

• Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin.

  Journal of clinical psychopharmacology 20010401

• Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.

  Clinical pharmacology and therapeutics 20010401

• Noradrenergic dysfunction and antidepressant treatment response.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010401

• A case of resistant trichotillomania treated with risperidone-augmented fluvoxamine.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010401

• Increased libido in a woman treated with fluvoxamine: a case report.

  Acta psychiatrica Scandinavica 20010401

• The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.

  The Journal of pharmacy and pharmacology 20010401

• Problems with ensuring a double blind.

  The Journal of clinical psychiatry 20010401

• Effect of fluvoxamine and N-methyl-D-aspartate receptor antagonists on shock-induced depression in mice.

  Indian journal of physiology and pharmacology 20010401

• Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010301

• Effect of fluvoxamine on the pharmacokinetics of mexiletine in healthy Japanese men.

  Clinical pharmacology and therapeutics 20010301

• Alleviation of sleep disturbance and repetitive behavior by a selective serotonin re-uptake inhibitor in a boy with Asperger's syndrome.

  Brain & development 20010301

• An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa.

  The Journal of clinical psychiatry 20010301

• Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes.

  European journal of clinical pharmacology 20010301

• Comparison of noradrenergic and serotonergic antidepressants in reducing immobility time in the tail suspension test.

  Japanese journal of pharmacology 20010301

• Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice.

  Neuroscience letters 20010216

• Psychopharmacologic treatment of adolescent depression.

  Archives of psychiatric nursing 20010201

• Phenytoin intoxication induced by fluvoxamine.

  Therapeutic drug monitoring 20010201

• Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010201

• Fluvoxamine for psychosis in Alzheimer's disease.

  The Journal of nervous and mental disease 20010201

• Restlessness related to SSRI withdrawal.

  Psychiatry and clinical neurosciences 20010201

• Serum fluvoxamine levels in breastfed infants.

  The Journal of clinical psychiatry 20010201

• Sexual dysfunction and fluvoxamine therapy.

  The Journal of clinical psychiatry 20010201

• Priapism associated with polypharmacy.

  The Journal of clinical psychiatry 20010201

• Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.

  The Journal of clinical psychiatry 20010201

• Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures.

  Clinical therapeutics 20010201

• [The transfer of selective serotonin reuptake inhibitors to human milk].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20010120

• Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide.

  Clinical pharmacology and therapeutics 20010101

• Fluvoxamine approved for treating OCD in children.

  Journal of psychosocial nursing and mental health services 20010101

• A case of adolescent body dysmorphic disorder treated with fluvoxamine.

  Journal of child and adolescent psychopharmacology 20010101

• [Wernicke-Korsakoff syndrome: malignant tumour as triggering factor].

  Actas espanolas de psiquiatria 20010101

• SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

  Clinical neuropharmacology 20010101

• Determination of moclobemide, paroxetine, and fluvoxamine in tablets by HPLC.

  Acta poloniae pharmaceutica 20010101

• A subtype of auditory verbal hallucinations responds to fluvoxamine.

  The Journal of neuropsychiatry and clinical neurosciences 20010101

• [Therapeutic action and efficiency of fevarin (fluvoxamine) in patients with non-psychotic anxious and apathic-adynamic depressions].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20010101

• The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.

  The Journal of clinical psychiatry 20010101

• Predictive value of amino acids in the treatment of major depression with fluvoxamine.

  Neuropsychobiology 20010101

• Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats.

  Pharmacology 20010101

• Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study.

  Psychotherapy and psychosomatics 20010101

• Fluvoxamine as an adjunctive agent in schizophrenia.

  CNS drug reviews 20010101

• A case of Korsakoff's syndrome improved by high doses of donepezil.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20010101

• Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.

  Paediatric drugs 20010101

• Fluvoxamine treatment of a child with severe PDD: a single case study.

  Psychiatry 20010101

• [Fluvoxamine (fevarin) in psychogenic depression].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20010101

• Methadone, ciprofloxacin, and adverse drug reactions.

  Lancet (London, England) 20001216

• Seizure possibly associated with fluvoxamine.

  The Annals of pharmacotherapy 20001101

• [Three cases of severe hyponatremia under taking selective serotonin reuptake inhibitor (SSRI)].

  Nihon Jinzo Gakkai shi 20001001

• Low dosage of levomepromazine did not increase plasma concentrations of fluvoxamine.

  International clinical psychopharmacology 20000701

• Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.

  Biological psychiatry 20000501

• [Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine].

  Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20000501

• Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 19991201

• Movement disorders associated with fluvoxamine.

  Journal of the American Academy of Child and Adolescent Psychiatry 19990801

• Adverse effects of pindolol augmentation in patients with bipolar depression.

  Journal of clinical psychopharmacology 19990801

• Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy.

  The Journal of clinical psychiatry 19990301

• Acute dystonia associated with fluvoxamine-metoclopramide.

  The Annals of pharmacotherapy 19990301

• Extrapyramidal symptoms after addition of fluvoxamine to clozapine.

  Journal of clinical psychopharmacology 19981201

• Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior.

  The American journal of psychiatry 19981101

• Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.

  Journal of clinical psychopharmacology 19980801

• Fluvoxamine-induced erectile dysfunction responding to sildenafil.

  Journal of sex & marital therapy 19980101

• Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.

  Biological psychiatry 19970801

• Fluoxetine-induced Raynaud's phenomenon.

  Biological psychiatry 19970615

• Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity.

  Archives of internal medicine 19970609

• Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment.

  The British journal of psychiatry : the journal of mental science 19970601

• The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.

  European journal of pharmacology 19970501

• Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

  The Journal of clinical psychiatry 19970401

• A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.

  The Journal of clinical psychiatry 19970401

• Griseofulvin and fluvoxamine interactions with the metabolism of theophylline.

  Therapeutic drug monitoring 19970201

• SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

  Journal of sex & marital therapy 19970101

• Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation.

  Psychopharmacology 19961201

• Treatment of fluvoxamine-induced anorgasmia with a partial drug holiday.

  The American journal of psychiatry 19961001

• Serotonin reuptake inhibitor withdrawal.

  Journal of clinical psychopharmacology 19961001

• A comparison of fluvoxamine and fluoxetine in the treatment of major depression.

  Journal of clinical psychopharmacology 19961001

• Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 19960901

• Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group.

  International clinical psychopharmacology 19960901

• Antidepressant-induced hypomania in obsessive-compulsive disorder.

  International clinical psychopharmacology 19960901

• Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients.

  Clinical neuropharmacology 19960801

• A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.

  Journal of clinical psychopharmacology 19960801

• Fluvoxamine for premenstrual dysphoric disorder: a pilot study.

  The Journal of clinical psychiatry 19960101

• [Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients].

  Actas luso-espanolas de neurologia, psiquiatria y ciencias afines 19960101

• Severe myoclonus produced by fluvoxamine.

  The Journal of clinical psychiatry 19951201

• Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.

  The Journal of clinical psychiatry 19951101

• Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors.

  Clinical neuropharmacology 19950801

• Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient.

  International clinical psychopharmacology 19950601

• A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder.

  Pharmacopsychiatry 19950501

• Overview of the pharmacokinetics of fluvoxamine.

  Clinical pharmacokinetics 19950101

• Sinus bradycardia due to fluvoxamine overdose.

  The British journal of psychiatry : the journal of mental science 19941001

• Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.

  The Journal of clinical psychiatry 19940701

• Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder.

  The British journal of psychiatry : the journal of mental science 19940601

• Behavioral side effects in obsessive-compulsive patients treated with fluvoxamine: a clinical description.

  Journal of clinical psychopharmacology 19940201

• Fluvoxamine-associated sexual dysfunction.

  The Annals of pharmacotherapy 19940101

• Serotonin syndrome induced by fluvoxamine-lithium interaction.

  Pharmacopsychiatry 19931101

• Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors.

  Acta psychiatrica Scandinavica 19931001

• Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients.

  The Journal of clinical psychiatry 19930601

• The abrupt discontinuation of fluvoxamine in patients with panic disorder.

  The Journal of clinical psychiatry 19930401

• Syndrome of inappropriate antidiuretic hormone secretion due to fluvoxamine therapy.

  The British journal of clinical practice 19930101

• Seizures induced by combined levomepromazine-fluvoxamine treatment.

  International clinical psychopharmacology 19930101

• A fluvoxamine-induced frontal lobe syndrome in a patient with comorbid Gilles de la Tourette's syndrome and obsessive compulsive disorder.

  The Journal of clinical psychiatry 19921001

• Fluvoxamine can induce confusion in the elderly.

  Journal of clinical psychopharmacology 19920801

• Extrapyramidal symptoms in a patient treated with fluvoxamine.

  Journal of neurology, neurosurgery, and psychiatry 19920401

• [Fluvoxamine. Study of treatment effect on a group of 189 hospitalized patients with depression].

  L'Encephale 19920101

• Serotonin reuptake inhibitors, epilepsy and myoclonus.

  The British journal of psychiatry : the journal of mental science 19910901

• Fluoxetine, fluvoxamine and extrapyramidal tract disorders.

  International clinical psychopharmacology 19910101

• Fluvoxamine and lithium: an unusual interaction.

  The British journal of psychiatry : the journal of mental science 19900201

• Some central effects of repeated treatment with fluvoxamine.

  Polish journal of pharmacology and pharmacy 19890101

• Recovery from prolonged cerebral depression after fluvoxamine overdose.

  British medical journal (Clinical research ed.) 19880625

• A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.

  The Journal of clinical psychiatry 19850301

• Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model.

  Neuropsychobiology 19840101

• Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice.

  Journal of neural transmission 19820101